Adeliv is recommended as an additional source of ademetionine to normalize the functional state of the hepatobiliary system in intrahepatic cholestasis, which can be observed in fatty liver disease, chronic hepatitis, toxic liver lesions of various etiologies (including alcoholic, viral and drug-induced), chronic non-calculous cholecystitis, cholangitis, cirrhosis of the liver, encephalopathy associated with liver failure (including alcoholic). Neuroprotective properties determine the appropriateness of using Adeliv in depressive states.